This sector provides you market resarch, import & export data, company profiles, policy and trend analysis, etc....More
CRI expects that in the next few years, demand for pharmaceuticals will rise with increasing residents' income, upgrading consumption, aging population, accelerating urbanization and improving healthcare system, promoting the development of China's pharmaceutical industry.
According to CRI analysis, the Chinese society is aging and the medical industry is supported by the government.
In China, the market size exceeded CNY 130 billion in 2016, but its share in the pharmaceutical market was less than 10%, far below that in developed countries.
The total production value of chemical preparation in China shows a steady growing trend and increased from CNY 150.1 billion in 2006 to CNY 753.5 billion in 2016, with the CAGR of 17.5%.
CRI considers that China is the world's leading exporter of API and enjoys cost advantages compared with competitors. In the past decade, China's share of the global active pharmaceutical ingredient market has been increasing.
In 2016, the annual consumption per capita of China's in-vitro diagnostic products was less than USD 3, while that of developed countries reached USD 25 to USD 30.
According to CRI estimation, the market value of health examination was approximately CNY 80 billion in China in 2015. It is estimated to preserve a growth rate of over 10% each in the next few years.
Hemodialysis services mainly consist of dialyzers, dialysis consumables, dialysis drugs and labor services. Hemodialysis instruments include dialysis machines, dialyzers and dialysis pipelines. Dialyzers are core consumables with high technical barriers, which accounts for the largest market share.
The market size of Chinese hemodialysis market is expected to exceed CNY 70 billion in China by 2020 with the CAGR above 20%.
The number of medical institutions was 0.962 million by the end of November 2013, including 24,000 hospitals, 0.923 million primary medical institutions, 12,000 public medical institutions and 2,000 other institutions. The number of hospitals and public medical institutions increased by 1,564 and 247 respectively...
Benign prostatic hyperplasia (BPH) is a common disease among middle-aged and elderly men, with an increasing morbidity as the rise in ages. Its invasion is possibly related to race and regions.
Since OTC drugs are mainly used by consumers without a physician's prescription in treating certain common ailments which are easy for self-diagnosis and self-treatment, the structure of their terminal market is relatively stable.…
The elderly population in China will exceed 200 million by the end of 2013 and reach 221 million in 2015, accounting for 16% of the population, with a severe population aging trend.
Our support hotline is available 24/7.
Phone:86-21-68521029Contact our expert support team!